ZNF638 and colon adenocarcinoma: In addition, two of the MALAT1 targets shared across the small intestine and colon, ZNF638 and SENP8, are associated with a change in hazards ratio for overall survival and disease-free survival in human colon adenocarcinoma patients (Figure 6B).